PATIENT FOCUSED MEDICINE
Live / Registered — Registered and renewed (as of 09 Mar 2024)
What this means for you
Registered since 02 Apr 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Apr 2023).
Record
- Serial number
- 85763460
- Registration number
- 4313188
- Mark type
- Stylized text
- Filed
- 25 Oct 2012
- Published for opposition
- 15 Jan 2013
- Registered
- 02 Apr 2013
- Next maintenance due
- 02 Apr 2023
- Attorney of record
- Jeffrey S. Bernard
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes
Owner
- Asepsis Pharmaceuticals Inc., Sarasota, FL, US
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
Prosecution history
- 09 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Mar 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Mar 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Sept 2023 — TEAS SECTION 8 & 9 RECEIVED
- 02 Apr 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 09 May 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 09 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 May 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 May 2018 — TEAS SECTION 8 RECEIVED
- 30 Apr 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Apr 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Apr 2013 — REGISTERED-PRINCIPAL REGISTER
- 15 Jan 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED